ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.04
      1.10%
      US Tech 100
      21,198.40
      1.36%
      Dow Jones
      43,297.03
      0.91%
      Brent Oil
      73.335
      0.07%
      Bitcoin
      98,847.30
      -0.46%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Germany
      5. TG

      6. Johnson And Johnson (JNJ) Quote

      Johnson And Johnson

      Johnson And Johnson (JNJ)

      Johnson and Johnson
      Johnson and Johnson
      139.56
      1.04
      (0.75%)
      Closed December 25 4:00PM
      Realtime Data

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      139.56
      Bid
      139.32
      Ask
      139.76
      Volume
      7,921
      137.90 Day's Range 139.70
      132.74 52 Week Range 153.98
      Market Cap
      336.008B
      Previous Close
      138.52
      Open
      138.58
      Last Trade
      36
      @
      139.69999
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      8,631
      Shares Outstanding
      2,407,622,972
      Dividend Yield
      3.70%
      PE Ratio
      9.99
      Earnings Per Share (EPS)
      14.6
      Revenue
      85.16B
      Net Profit
      35.15B

      About Johnson And Johnson

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.jnj.com
      Headquarters
      New Brunswick, New Jersey, USA
      Founded
      -
      Johnson And Johnson is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker JNJ. The last closing price for Johnson And Johnson was 138.52 €. Over the last year, Johnson And Johnson shares have traded in a share price range of 132.74 € to 153.98 €.

      Johnson And Johnson currently has 2,407,622,972 shares outstanding. The market capitalization of Johnson And Johnson is 333.50 € billion. Johnson And Johnson has a price to earnings ratio (PE ratio) of 9.99.

      Ask ADVFN Intelligence (AI)

      JNJ Latest News

      More News

      Johnson & Johnson to Participate in RBC Capital Markets' Health Care Conference

      NEW BRUNSWICK, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Johnson & Johnson will participate in the RBC Capital Markets' Health Care Conference on Tuesday, March 2, 2010, at the New York Palace...

      February 23 2010
      PR Newswire (US)

      Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes

      Cordis to Receive $1.725 Billion BRIDGEWATER, N.J., Feb. 1 /PRNewswire/ -- Cordis Corporation, a Johnson & Johnson company, announced today that it has reached an agreement with Boston Scientific...

      February 01 2010
      PR Newswire (US)

      Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results:

      2009 Fourth-Quarter Sales of $16.6 Billion increased 9.0%; EPS was $0.79 2009 Full-Year Sales of $61.9 Billion decreased 2.9%; Full-Year EPS was $4.40 Excluding Special Items, 2009 Fourth-Quarter...

      January 26 2010
      PR Newswire (US)

      Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2009 Financial Results

      NEW BRUNSWICK, N.J., Jan. 19 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, January 26, 2010, to discuss fourth-quarter and...

      January 19 2010
      PR Newswire (US)

      Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (ri

      TITUSVILLE, N.J., Dec. 10 /PRNewswire/ -- Treatment with once-monthly INVEGA® SUSTENNA(TM) is not inferior to treatment with bi-weekly RISPERDAL® CONSTA®, according to new data from a...

      December 10 2009
      PR Newswire (US)

      Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact Lenses

      ORLANDO, Fla., Nov. 11 /PRNewswire-FirstCall/ -- Contact lenses prescribed for longer replacement intervals can lead to more extreme over wear (stretching) that could lead to undesirable...

      November 11 2009
      PR Newswire (US)

      VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmolo

      Telescope Prosthesis for End-Stage Macular Degeneration Highlighted SARATOGA, Calif., Oct. 20 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic...

      October 20 2009
      PR Newswire (US)

      New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis

      Patients with Active Rheumatoid Arthritis Receiving SIMPONI Demonstrated Sustained Improvements in Signs and Symptoms Through One Year PHILADELPHIA, Oct. 19 /PRNewswire/ -- New long-term data...

      October 19 2009
      PR Newswire (US)

      New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis

      Results from Radiographic Analyses Show Efficacy of SIMPONI in Inhibiting Joint Destruction in Two Rheumatic Conditions PHILADELPHIA, Oct. 19 /PRNewswire/ -- Phase 3 data reported for the first...

      October 19 2009
      PR Newswire (US)

      Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Medical Devices & Diagnostics Bu

      NEW BRUNSWICK, N.J., Oct. 6 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, Oct. 13, 2009, to discuss third-quarter financial...

      October 06 2009
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      100139.56140.84136.5214268138.65669395DE
      4-9.66-6.47366304785149.22149.38136.5210082141.47194507DE
      12-5.06-3.4988245056144.62153.97999136.528631145.21426781DE
      260.340.244217784801139.22153.97999133.699998441144.77917636DE
      52-0.44-0.314285714286140153.97999132.749192143.22505246DE
      156-8.42-5.68995810245147.98178.26132.746037148.43501767DE
      2607.285.50347747203132.28178.26104.127632139.83269408DE

      JNJ - Frequently Asked Questions (FAQ)

      What is the current Johnson And Johnson share price?
      The current share price of Johnson And Johnson is 139.56 €
      How many Johnson And Johnson shares are in issue?
      Johnson And Johnson has 2,407,622,972 shares in issue
      What is the market cap of Johnson And Johnson?
      The market capitalisation of Johnson And Johnson is EUR 333.5B
      What is the 1 year trading range for Johnson And Johnson share price?
      Johnson And Johnson has traded in the range of 132.74 € to 153.98 € during the past year
      What is the PE ratio of Johnson And Johnson?
      The price to earnings ratio of Johnson And Johnson is 9.99
      What is the cash to sales ratio of Johnson And Johnson?
      The cash to sales ratio of Johnson And Johnson is 4.12
      What is the reporting currency for Johnson And Johnson?
      Johnson And Johnson reports financial results in USD
      What is the latest annual turnover for Johnson And Johnson?
      The latest annual turnover of Johnson And Johnson is USD 85.16B
      What is the latest annual profit for Johnson And Johnson?
      The latest annual profit of Johnson And Johnson is USD 35.15B
      What is the registered address of Johnson And Johnson?
      The registered address for Johnson And Johnson is ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK, NEW JERSEY, 08933
      What is the Johnson And Johnson website address?
      The website address for Johnson And Johnson is www.jnj.com
      Which industry sector does Johnson And Johnson operate in?
      Johnson And Johnson operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      013CJDcom Inc
      17.426 €
      (0.00%)
      		0
      013AJD.com Inc
      34.90 €
      (0.00%)
      		0
      0110Thesis Gold Inc
      0.391 €
      (0.00%)
      		0
      00WAspermont Ltd
      0.004 €
      (0.00%)
      		0
      000Greenvolt Energias Renovaveis SA
      0.00 €
      (0.00%)
      		0
      WWTWater Ways Technologies Inc
      0.0045 €
      (-95.91%)
      		2.53k
      L7C2Windfall Geotek Inc
      0.0025 €
      (-70.59%)
      		40k
      QP9Atco Mining Inc
      0.003 €
      (-55.88%)
      		1.5k
      0PV2Moovly Media Inc
      0.002 €
      (-55.56%)
      		500
      8QPFidus Investment Corp
      9.5899 €
      (-51.32%)
      		220
      013CJDcom Inc
      17.426 €
      (0.00%)
      		0
      013AJD.com Inc
      34.90 €
      (0.00%)
      		0
      0110Thesis Gold Inc
      0.391 €
      (0.00%)
      		0
      00WAspermont Ltd
      0.004 €
      (0.00%)
      		0
      000Greenvolt Energias Renovaveis SA
      0.00 €
      (0.00%)
      		0

      Discussion

      View Full Feed
      boi568 boi568 5 minutes ago
      Your AI generated response of 20 to 60 months to finalize agency guidance reads to me as a start-to-finish time line. It is not in the ballpark for finalizing after draft guidance publication and receipt of supportive comments. The government can be slow forming policy, but not anywhere near that sl
      AVXL
      getmoreshares getmoreshares 10 minutes ago
      all the coal yards are long gone-- Miss those days.
      getmoreshares getmoreshares 11 minutes ago
      you might be near me!!!! E.TN
      CGAC
      tmcfo tmcfo 11 minutes ago
      If that is the case, then it is worth it to write this letter?
      MVNT
      getmoreshares getmoreshares 12 minutes ago
      yes- open
      CGAC
      pos_stock_hoarder pos_stock_hoarder 12 minutes ago
      I don't want to brag or anything, but mine was LOW SULFUR!
      StayHumble StayHumble 13 minutes ago
      New CE0💹KevinLamb💹T0P10 Healthcare innovators💹fOrbes wow! $UBQU
      https://x.com/CorporateUbqu/status/1802724359762506049
      https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
      UBQU
      stealofadeal stealofadeal 15 minutes ago
      $BLTH Wrong pal with confirmation they will get all the needed money to move forward without doubt. The valuation of this company is over 150 million as is and the market cap is under 10 million right now. WAY UNDERVALUED!
      BLTH
      Welcome2Pinkyland Welcome2Pinkyland 16 minutes ago
      MERRY CHRISTMAS! BFB AND ALL❤️
      Hestheman47 Hestheman47 17 minutes ago
      We will soon be getting a new SEC chairman. Hopefully he will be for deregulation and will roll back the market killing amendments that were made with 15c2-11 back in 2019-2020. There are over 3k stocks on the expert market......we need to open those stocks up to retail again. Move them to Pink Unli
      Hosai Hosai 21 minutes ago
      A few days back Jesse Brodkin posted a screenshot showing the edit history from the clinical trials site which shows Anavex downgraded the sleep measure from secondary end point to 'other outcome measures' on 12th July 2022 as-well as some minor (non significant) changes to wording in others. This w
      AVXL
      Bionic Man Bionic Man 25 minutes ago
      Yes, the market is open tomorrow 
      CGAC
      janice shell janice shell 33 minutes ago
      LOLOLOL!!
      skitahoe skitahoe 33 minutes ago
      I've learned through the years to never call anything 100%. I've seen the FDA accept everything that was submitted and met all the criteria they established for approval, but they still asked a question which took another small trial to answer. It was a stupid delay, no telling how many lives were
      NWBO
      sam1933 sam1933 33 minutes ago
      🚨BREAKING: Apple is joining the $HBAR governing council in 2025

      🚨BREAKING: According to internal sources, Apple is joining the $HBAR
      HBAR
      gitreal gitreal 34 minutes ago
      Is it "fun" participating in securities fraud?
      NBRI
      firebag1 firebag1 35 minutes ago
      Does trading commence tomorrow?
      TNXP
      firebag1 firebag1 36 minutes ago
      Are markets open tomorrow morning?
      CGAC
      Steady_T Steady_T 37 minutes ago
      You know you are fighting a losing battle when you have been posting negatively on a stock for 7 years and the stock is on the edge of having a drug approved.

      Time to reconsider?
      NWBO
      glenn1919 glenn1919 40 minutes ago
      muln................................................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
      MULN
      delerious1 delerious1 40 minutes ago
      So what do you think NBRI shareholders...nothing in this life is guaranteed, but I think we have a major shot at having some serious fun...should be good....
      NBRI
      goldenpath8 goldenpath8 41 minutes ago
      More Fake Meat = More Depression
      visit - www.cogwriter.com - see link same as above title
      AVXL

      Your Recent History

      TG
      JNJ
      Johnson And Johnson
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads